Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Sulfonylureas and Cardiac Outcomes Evaluated

Diabetes Care; ePub 2018 Feb 2; Leonard, et al

Patients who take glyburide may be less likely than those receiving glipizide to experience sudden cardiac arrest (SCA) and ventricular arrhythmia (VA), according to a retrospective cohort study involving >500,000 individuals. Participants’ average age was 58 years. Investigators analyzed 1999–2010 Medicaid claims from 5 large states, looking at SCA/VA incidence in patients who took glyburide, glimepiride, or glipizide. Among the results:

  • 632 SCA/VA events were seen in ~177,000 person-years of sulfonylurea exposure.
  • >Half of the events were immediately fatal (3.6/1,000 person-years).
  • Patients taking glyburide were 18% less likely to experience SCA/VA compared with those who took glipizide.
  • Patients taking glimepiride were 10% more likely to experience such.

The authors noted that it is important to also consider the effects different sulfonylureas have on other cardiovascular and cerebrovascular outcomes, all-cause death, and hypoglycemia.

Citation:

Leonard C, Brensinger C, Aquilante C, et al. Comparative safety of sulfonylureas and the risk of sudden cardiac arrest and ventricular arrhythmia. [Published online ahead of print February 2, 2018]. Diabetes Care. doi:10.2337/dc17-0294.

This Week's Must Reads

MetS Severity Z Score Helps Track T2D Treatment , Diabetes Care; ePub 2018 Oct 1; DeBoer, et al

Are T1D and Hearing Impairment Associated? , Diabetes Care; ePub 2018 Sep 25; Schade, et al

Look AHEAD Lifestyle Intervention Proves Effective, Obesity; 2018 Oct; Krukowski, Hare, et al

FDA Approves Xyosted for Testosterone Replacement, Antares Pharma news release; 2018 Oct 1

Glycemic Control, Dementia Risk in Type 1 Diabetes, Diabetes Care; ePub 2018 Sep 4; Lacy, Gilsanz, et al

Must Reads in Diabetes

MetS Severity Z Score Helps Track T2D Treatment , Diabetes Care; ePub 2018 Oct 1; DeBoer, et al

Are T1D and Hearing Impairment Associated? , Diabetes Care; ePub 2018 Sep 25; Schade, et al

Look AHEAD Lifestyle Intervention Proves Effective, Obesity; 2018 Oct; Krukowski, Hare, et al

Glycemic Control, Dementia Risk in Type 1 Diabetes, Diabetes Care; ePub 2018 Sep 4; Lacy, Gilsanz, et al

Diabetes, Coronary Artery Calcium in Subpopulations, Diab Vasc Dis Res; ePub 2018 Aug 16; Mamudu, et al